HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
34.31 USD
-0.36 (-1.04%)
34.02 USD
-0.29 (-0.85%)
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS has a Return On Assets of 5.99%. This is amongst the best in the industry. HIMS outperforms 82.18% of its industry peers.
The Return On Equity of HIMS (23.03%) is better than 90.10% of its industry peers.
With a decent Return On Invested Capital value of 5.84%, HIMS is doing good in the industry, outperforming 60.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.05%, HIMS belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
The Operating Margin of HIMS (5.96%) is better than 65.35% of its industry peers.
Looking at the Gross Margin, with a value of 75.01%, HIMS belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
HIMS has more shares outstanding than it did 5 years ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 4.15. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS has a better Altman-Z score (4.15) than 76.24% of its industry peers.
HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
The Debt to Equity ratio of HIMS (1.67) is worse than 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.15 |
ROIC/WACC0.65
WACC8.96%
2.3 Liquidity
HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a Current ratio of 1.88. This is in the better half of the industry: HIMS outperforms 75.25% of its industry peers.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.64, HIMS is doing good in the industry, outperforming 65.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.02%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.08% on average over the next years. This is a very strong growth
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 63.54, which means the current valuation is very expensive for HIMS.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 57.25, HIMS can be considered very expensive at the moment.
HIMS's Price/Forward Earnings is on the same level as the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.54 | ||
| Fwd PE | 57.25 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.37 | ||
| EV/EBITDA | 45.15 |
4.3 Compensation for Growth
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
HIMS's earnings are expected to grow with 13.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)1.05
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.31
-0.36 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.86%
Ins Owners5.88%
Ins Owner Change-3.41%
Market Cap7.81B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target46.4 (35.24%)
Short Float %32.86%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-5.57%
PT rev (3m)-9.7%
EPS NQ rev (1m)-65.22%
EPS NQ rev (3m)-81.79%
EPS NY rev (1m)-21.88%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.96%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.54 | ||
| Fwd PE | 57.25 | ||
| P/S | 3.53 | ||
| P/FCF | 65.37 | ||
| P/OCF | 24.03 | ||
| P/B | 13.44 | ||
| P/tB | 61.59 | ||
| EV/EBITDA | 45.15 |
EPS(TTM)0.54
EY1.57%
EPS(NY)0.6
Fwd EY1.75%
FCF(TTM)0.52
FCFY1.53%
OCF(TTM)1.43
OCFY4.16%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1.05
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.15 |
F-Score3
WACC8.96%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.63%
Revenue Next 3Y31.12%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to decline by -12.6% in the next year.